2QM Stock Overview

A technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally. More details

2QM fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	2/6
Past Performance	0/6
Financial Health	4/6
Dividends	0/6

Rewards

Revenue is forecast to grow 34.36% per year

Risk Analysis

Earnings have declined by 14.5% per year over past 5 years

Does not have a meaningful market cap (€2M)

Shares are highly illiquid

Shareholders have been diluted in the past year

My Notes

Capture your thoughts, links and company narrative

Xylo Technologies Ltd Competitors

Audientes

DB:AUG

€6.9m

aap Implantate

XTRA:AAQ1

€15.6m

Geratherm Medical

XTRA:GME

€18.4m

PULSION Medical Systems

MUN:PUS

€133.6m

Price History & Performance

Summary of share price highs, lows and changes for Xylo Technologies
Historical stock prices
Current Share Price	US$4.37
52 Week High	US$5.92
52 Week Low	US$3.52
Beta	1.46
1 Month Change	0%
3 Month Change	-19.61%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-18.00%

Recent updates

Shareholder Returns

	2QM	DE Medical Equipment	DE Market
7D	0%	-3.0%	-2.6%
1Y	n/a	-7.8%	7.1%

Return vs Industry: Insufficient data to determine how 2QM performed against the German Medical Equipment industry.

Return vs Market: Insufficient data to determine how 2QM performed against the German Market.

Price Volatility

Is 2QM's price volatile compared to industry and market?
2QM volatility
2QM Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	6.7%
Market Average Movement	4.9%
10% most volatile stocks in DE Market	11.6%
10% least volatile stocks in DE Market	2.5%

Stable Share Price: 2QM's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine 2QM's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1999	84	Liron Carmel	www.medigus.com

Xylo Technologies Ltd, a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally. The company operates through Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and Others segments. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease.

Xylo Technologies Ltd Fundamentals Summary

How do Xylo Technologies's earnings and revenue compare to its market cap?
2QM fundamental statistics
Market cap	€2.17m
Earnings (TTM)	-€14.79m
Revenue (TTM)	€53.30m

0.0x

P/S Ratio

-0.1x

P/E Ratio

Is 2QM overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2QM income statement (TTM)
Revenue	US$57.64m
Cost of Revenue	US$49.84m
Gross Profit	US$7.80m
Other Expenses	US$23.79m
Earnings	-US$15.99m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-21.84
Gross Margin	13.53%
Net Profit Margin	-27.74%
Debt/Equity Ratio	40.7%

How did 2QM perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/10/30 03:28
End of Day Share Price	2024/08/02 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Xylo Technologies Ltd is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Rommel Dionisio	Aegis Capital Corporation
Jeffrey Cohen	Ladenburg Thalmann & Company
Christopher Lewis	Roth MKM

Xylo Technologies DB:2QM Stock Report